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ABSTRACT 
Ting-Jia Fan: The Role of Enterococcus faecalis Sugar Transport in Experimental Colitis 
(Under the direction of Jonathan J. Hansen and R. Balfour Sartor) 
 
Inflammatory bowel diseases (IBDs), which afflict 1.6 million people in the United States, 
are chronic, relapsing and immune-mediated intestinal disorders caused in part by aggressive T-
cell-mediated immune responses to intestinal microbes in genetically susceptible individuals. 
However, relatively little is known about how intestinal inflammation affects the function of gut 
microbiota. We show that Il10-/- mice colonized with a simplified, defined microbial consortium 
that includes Enterococcus faecalis develop immune-mediated colitis. Transcription of two 
putative E. faecalis phosphotransferase systems (PTS) that import sugars into the bacterium is 
upregulated in colitis. We identify gluconate, ribose, and glucosamine as potential substrates for 
these PTS. The presence of these PTS is associated with altered intestinal microbial ecology and 
worsened colitis, therefore suggesting a role for E. faecalis sugar metabolism in colitis 
development. This work highlights the complexity of host-microbial-environmental interactions 
underlying colitis development and could enable the development of safe and effective 
treatments for IBDs. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Inflammatory bowel diseases (IBDs) 
Inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis 
(UC), are chronic, relapsing immune-mediated inflammatory disorders of the intestines (Sartor, 
2006; Sartor & Wu, 2017). CD is a condition of chronic inflammation in any location of the 
gastrointestinal tract and UC is a chronic gastrointestinal disorder that is limited to the large 
bowel (Khor, Gardet, & Xavier, 2011). An estimated 1.6 million people in the United States 
currently have IBDs and as many as 70,000 new cases of IBD are diagnosed each year (Loftus, 
2016; Shivashankar, Tremaine, Harmsen, & Loftus, 2017). An estimated direct and indirect 
annual medical cost of IBDs in United States is between $14.6 and $31.6 billion (Mehta, 2016). 
The incidence and prevalence of IBDs has steadily increased in developing countries and has 
been attributed to these country’s adoption of a Westernized lifestyle (M'Koma, 2013). 
Currently, IBDs cannot be cured medically and surgical treatments for CD offer only temporary 
relief (Hansen & Sartor, 2015). Most effective medical therapies for IBDs are immune 
suppressing and therefore associated with potentially toxic side effects (Baumgart & Sandborn, 
2012; Ordás, Eckmann, Talamini, Baumgart, & Sandborn, 2012). Therefore, alternative new and 
effective treatments that do not cause significant sides effects are needed. 
1.2 Pathogenesis of IBDs 
Although the exact causes of IBDs are unknown, a prevailing hypothesis is that the 
etiology of IBDs is a combination of genetic susceptibility, dysregulated immune responses, 
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environmental triggers and altered resident intestinal microbes (Sartor, 2006). The large-scale 
genome-wide association studies (GWAS) have shown more than 200 genetic loci that are 
associated with IBDs and many of these IBD risk loci are in gene regions that encode proteins 
involved in innate/adaptive immune responses, mucosal barrier function and bacterial clearance 
(Jostins et al., 2012; Liu et al., 2015).  
In addition to GWAS, immunological studies also implicate maladaptive immune 
responses in the pathogenesis of IBDs. Activated macrophages and dendritic cells in the lamina 
propria are increased in IBD patients (Sartor, 2006; Sartor & Wu, 2017), and most pro-
inflammatory cytokines and chemokines, such as interleukin (IL)-1ß, tumor necrosis factor 
(TNF), IL-6, IL-8, IL-12, and IL-18, are also increased in both CD and UC (Sartor, 2006). 
Dysfunctional immune regulation in IBDs results in innate/adaptive immune cells, such as 
macrophages, dendritic cells, neutrophils and T cells, being recruited into the inflamed intestine 
and then releasing pro-inflammatory cytokines and chemokines prolonging inflammation (Sartor, 
2006; Sartor & Hoentjen, 2005).   
Some studies show that environmental factors also contribute to the pathogenesis of IBDs. 
For instance, infection, diet, antibiotic and nonsteroidal anti-inflammatory drug usage, stress, and 
smoking may initiate or perpetuate dysregulated immune responses (Loftus, 2004; Sartor, 2006). 
Altered resident intestinal microbial composition, also known as microbial dysbiosis, is 
associated with IBDs (Bibiloni, Mangold, Madsen, Fedorak, & Tannock, 2006; Sartor & Wu, 
2017). Although there is no direct evidence that intestinal microbiota cause human IBDs, several 
studies provide indirect evidence that intestinal microbes may play a role in development of 
IBDs (Sartor, 2008; Sartor & Wu, 2017). For example, fecal stream diversion for 3 to 6 months 
prevents Crohn’s inflammation; however, inflammation recurs after restoration of fecal flow 
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(D'Haens et al., 1998; Rutgeerts et al., 1991). In summary, our current understanding of 
molecular mechanisms of IBDs pathogenesis is that environmental triggers initiate and 
perpetuate aggressive T-cell-mediated immune responses to specific intestinal microbiota 
components in genetically susceptible individuals (Hansen, 2015; Sartor & Wu, 2017).  
1.3 Intestinal microbiota and IBDs 
The distal-intestinal tract harbors the highest concentration of resident microbial 
communities, known as intestinal microbiota, in the human body and provides an interface for 
intestinal microbiota to interact with the host through complex molecular cross-talk (Montalto, 
D'onofrio, Gallo, Cazzato, & Gasbarrini, 2009). At birth, the gastrointestinal tract is quickly 
colonized with maternal or environmental microbes. The intestinal microbiota increases in 
complexity and stability over the first two years of life before maturation into an adult state 
(Koenig et al., 2011; S. Subramanian et al., 2014). The majority of the normal adult enteric 
microbiota belong to bacterial phyla Firmicutes and Bacteroidetes, followed by Proteobacteria, 
Actinobacteria, Verrucomicrobia and Fusobacteria that are present in lesser abundance (Eckburg 
et al., 2005). The intestinal microbiota is commonly referred to as a hidden “organ” because they 
are important for normal intestinal development, homeostasis and protection against pathogen 
infection. Moreover, intestinal microbiota also impact host metabolism, physiology, nutrition and 
immune function (Guinane & Cotter, 2013). 
IBDs are associated with altered composition of specific groups of intestinal bacteria 
(Darfeuille-Michaud et al., 2004; Lepage et al., 2011; Q. Li, Wang, Tang, Li, & Li, 2012; 
Martinez Medina, Aldeguer, Gonzalez Huix, Acero, & Garcia Gil, 2006; Sokol et al., 2008). For 
example, IBDs are associated with decreased microbial biodiversity/richness and decreased 
compositional stability. Recently, a large microbiome study in human IBDs found that mucosal 
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biopsies from pediatric patients with new onset CD were more likely to have increased 
abundance of Enterobacteriaceae, Pasteurellaceae, Veillonellaceae and Fusobacteriaceae, and 
decreased abundance in Erysipelotrichales, Bacteroidales and Clostridiales, which findings are 
consistent with the prior studies (Gevers et al., 2014). Interestingly, in this same cohort, 
microbial compositional shifts in biopsies from inflamed ilea were also observed in biopsies of 
non-inflamed ilea, suggesting that microbiota changes may be the cause rather that the result of 
inflammation (Haberman et al., 2014). Despite recent advanced molecular sequencing 
technologies to characterize complex microbial communities, direct evidence that microbes 
cause human IBDs is still lacking. 
1.4 The Il10-/- mouse model of chronic, immune-mediated colitis 
The most direct evidence that intestinal microbes cause IBDs comes from experiments in 
rats and mice, including interleukin-10-deficient (Il10-/-) mice. IL-10 is an anti-inflammatory 
cytokine that limits the innate/adaptive immune response to pathogens and prevents damage to 
host tissues, and is therefore important to the maintenance of mucosal homeostasis (Saraiva & 
O'Garra, 2010).  Il10-/- mice raised in conventional housing facilities develop spontaneous 
chronic intestinal inflammation characterized by body weight loss, immune cells infiltration and 
distortion of crypt architecture (Kühn, Löhler, Rennick, Rajewsky, & Müller, 1993). However, 
the chronic intestinal inflammation is attenuated in Il10-/- mice raised under specific pathogen 
free (SPF)  conditions and is absent in Il10-/- mice raised in sterile, germ-free (GF) conditions  
(Berg et al., 1996; Sellon et al., 1998). 
Selective colonization of mice using defined bacterial strains, known as gnotobiotics, 
demonstrates that specific resident microbial taxa exhibit varying abilities to induce intestinal 
inflammation in these mice.  For example, Il10-/- mice develop colitis when mono-colonized with 
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a single strain of adherent invasive Escherichia coli (AIEC), NC101, but not when colonized 
with a non-AIEC E. coli strain, K12 (Ellermann et al., 2015; Kim, Tonkonogy, Jarvis, 
Darfeuille-Michaud, & Sartor, 2008). Similarly, GF Il10-/- mice also develop colitis when 
colonized with a defined consortium of non-pathogenic bacterial species, but the inflammation is 
less severe compared with SPF-colonized GF Il10-/- mice (Eun et al., 2014; Sellon et al., 1998). 
Importantly, GF wild-type (WT) mice do not exhibit any histological inflammation when mono-
colonized with NC101 or colonized with the defined consortium of bacterial species (Eun et al., 
2014; Patwa et al., 2011). Taken together, these studies highlight the power of gnotobiotic 
animal experiments to demonstrate that bacteria cause disease and to decipher some of the 
complex host-microbe interactions. Gnotobiotic animals also provide a more clinically-relevant 
environment than lab culture media to study interactions between different microbes in the 
intestine. In this work, we use gnotobiotic Il10-/- mice to study inter-species bacterial interactions 
in the gut and the resulting impact on experimental colitis. 
1.5 Enterococcus faecalis 
In addition to E. coli, other bacterial species have been implicated in human IBDs and 
experimental colitis.  For instance, Enterococcus species are more abundant in mucosal biopsies 
from IBDs patients vs. controls (Chen et al., 2014; De Cruz et al., 2015).  Specifically, 
Enterococcus faecalis, a non-motile, Gram-positive, facultative anaerobe, is more abundant in 
feces from CD patients vs. healthy controls (Zhou et al., 2016).  In mono-colonized Il10-/- mice, 
E. faecalis induces a slower-onset, distal colon-predominant inflammation, which progresses to 
severe distal colitis and duodenal inflammation at later time points (Kim et al., 2005). E. faecalis 
and E. coli dual-colonized Il10-/- mice develop more rapid onset and aggressive pancolitis and 
duodenal inflammation than mono-colonized mice (Kim, Tonkonogy, Karrasch, Jobin, & Sartor, 
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2007). These findings suggest that E. faecalis causes experimental colitis and may contribute to 
human IBDs. 
1.6 Colitis-associated alterations in intestinal bacterial composition and transcription 
Although intestinal microbiota dysbiosis correlates with IBDs, how factors in the intestine 
affect gut microbial community structure and function is still unclear. These environmental 
factors include diet, antibiotics, and intestinal inflammation. Feeding pediatric Crohn’s disease 
patients exclusively with a liquid formula diet induces remission (Dunn et al., 2016; Lewis et al., 
2015) and is associated with increased intestinal microbial diversity (Dunn et al., 2016). Also, 
inflammation, antibiotic exposure and diet independently affect different microbial taxa in 
Crohn’s disease patients (Lewis et al., 2015).  
In addition to altered gut bacterial composition, IBDs are also associated with changes in 
gut bacterial function.  We have previously shown that host inflammation affects luminal 
bacterial functions, which in turn impacts the course of disease. For example, stress response 
gene expression is upregulated in luminal bacteria from GF Il10-/- mice mono-colonized with the 
E. coli NC101 and the presence of two of these stress response genes results in decreased colitis 
(Patwa et al., 2011; Tchaptchet et al., 2013).  
1.7 Carbohydrates and IBDs 
With the understanding that intestinal bacterial likely contribute to the pathogenesis of 
IBDs, manipulating the gut bacteria composition and function for therapeutic purposes is an 
attractive approach. While several studies have shown that dietary treatments change gut 
bacterial composition in the host (Lewis et al., 2015; Wu et al., 2011), there is no direct evidence 
to suggest that specific diets can prevent or cure IBDs. Recently, several studies have shown that 
nutritional approaches, including consuming specific dietary carbohydrates (Kakodkar, Farooqui, 
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Mikolaitis, & Mutlu, 2015; Knight-Sepulveda, Kais, Santaolalla, & Abreu, 2015; Olendzki et al., 
2014), reduce some symptoms of IBDs.   
Measuring fecal concentrations of carbohydrates in patients with IBDs may also help 
clarify the role of carbohydrates in the pathogenesis of IBDs.  Using 1H NMR spectroscopy of 
fecal extracts from UC patients and healthy control subjects, investigators found increased 
taurine, cadaverine, choline and glucose levels in UC compared with controls (Le Gall et al., 
2011).  Therefore, though not yet tested, it is possible that elevated glucose in the colon lumen of 
UC patients could cause dysbiosis and impact disease severity. Other investigators used a similar 
technique to measure fecal metabolites in the dextran sulfate sodium (DSS)-induced colitis 
mouse model (Hong et al., 2010). They found increased monosaccharides, glucose, xylose, and 
trimethylamine in the feces of mice with DSS colitis compared with healthy controls. While 
these studies correlate the presence of certain fecal carbohydrates with colitis, how these 
inflammation-associated changes in luminal carbohydrates affect the gut microbiota and 
perpetuate inflammation is unknown. 
1.8 Phosphotransferase system (PTS) 
Among the several pathways that bacteria employ to acquire and metabolize environmental 
carbohydrates, the phosphotransferase system (PTS) is commonly used by obligate and 
facultative anaerobes such as E. faecalis. There are 39 putative PTS in E. faecalis OG1RF based 
on NCBI genome annotation. The PTS consists of two cytoplasmic components, 
phosphoenolpyruvate (PEP)-dependent kinase enzyme I (EI) and heat-stable phosphoryl carrier 
protein (HPr), that are general PTS components involved in all PTS pathways. Unlike general 
PTS components, PTS enzyme II (EII) complexes are thought to be specific for each sugar 
substrate and consist of IIA, IIB, IIC, and sometimes IID proteins and/or protein domains 
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(Galinier & Deutscher, 2017). Deletion of any of the EII components of a given EII complex 
typically inhibits import of the cognate sugar substrate for that complex. PTS couples the 
transport of sugars across the cytoplasmic membrane with their phosphorylation so that these 
sugars can be used as carbon sources for metabolism (Deutscher et al., 2014). The PTS also 
serves as a signal transduction system that monitors carbohydrate utilization based on the flux of 
phosphate through the pathway and can also directly regulate the metabolism of non-PTS sugars 
(Deutscher et al., 2014).  
In addition to their influence on sugar metabolism, PTS can also affect the virulence of 
some bacterial pathogens.  For instance, three different pathogenic bacterial strains (Salmonella 
typhimurium, Staphylococcus aureus, and Haemophilus influenzae) deficient in EI exhibit 
attenuated virulence in a mouse model of peritonitis compared with parental strains (Kok, Bron, 
Erni, & Mukhija, 2003). In another study, Hondorp, et al. show that the virulence regulator Mga 
in group A Streptococcus (GAS) contains a phosphotransferase system regulatory domain that 
can be phosphorylated in vitro by the EI/HPr (Hondorp et al., 2013). Mutations in this regulatory 
domain of Mga are associated with attenuated invasive GAS skin disease in a mouse model. This 
study implicates PTS-mediated phosphorylation of Mga in bacterial virulence gene expression 
(Hondorp et al., 2013). Whether the presence of environmental carbohydrates impacts PTS-
mediated virulence gene expression remains to be determined. 
1.9 Thesis Aims 
While the role of gut bacteria in the pathogenesis of IBDs and experimental colitis is 
becoming increasingly clear, large knowledge gaps exist. For instance, how does intestinal 
inflammation affect gut bacterial transcription in more complex microbial communities? What is 
the role of bacterial carbohydrate metabolism in the pathogenesis of intestinal inflammation? 
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How might bacterial species interact with one another in the intestine to influence inflammation? 
In the present work, we hope to begin to answer these host-microbial-environmental interaction 
questions and hope by answering these questions could guide the development of new strategies 
and potentially novel treatment options for IBD patients. 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Animals and bacterial species 
Germ-free WT and Il10-/- mice on the 129S6/SvEv background were obtained from the 
National Gnotobiotic Rodent Resource Center (UNC-Chapel Hill). All mice were housed in 
sterilized cages and provided with sterilized food and drinking water ad libitum. Mice were 
colonized at 8 to 16 weeks of age with eight IBD or experimental colitis-related intestinal 
bacterial strains, namely, Escherichia coli NC101 (Kim et al., 2005), Lactobacillus rhamnosus 
GG,  Enterococcus faecalis OG1RF, Bacteroides thetaiotaomicron VPI-5482, Bacteroides 
vulgatus ATCC 8482, Faecalibacterium prausnitzii A2-165, Bifidobacterium longum subsp. 
Infantis ATCC 15697, and Ruminococcus gnavus VPI C7-9 (ATCC 29149), by oral gavage. 
Animal protocols were performed in accordance with American Association for Laboratory 
Animal Care standards and were approved by the UNC Institutional Animal Care and Use 
Committee. 
2.2 Histological analysis 
In WT or Il10-/- mice, inflammation in formalin fixed, hematoxylin and eosin stained 
sections of cecum, proximal colon, mid-colon, and distal colon was quantified in a blinded 
fashion and summed together as described previously (Patwa et al., 2011). 
2.3 Microbial RNA isolation and RNA-sequencing Analysis 
Total bacterial RNA was isolated from the cecal content of wild type and Il10-/- mice (n = 5 
mice/group) using a combination of bead beating and phenol:chloroform extraction as described 
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previously (Faith, McNulty, Rey, & Gordon, 2011). To deplete total microbial community RNA 
of 16S, 23S, 5S rRNA and tRNA species prior to synthesis of cDNA with random 
hexanucleotide primers, each fecal RNA preparation was subjected to column-based size-
selection and hybridization to custom biotinylated oligonucleotides directed at conserved regions 
of bacterial rRNA genes present in human gut communities, followed by streptavidin-bead based 
capture of the hybridized RNA sequences (Rey et al., 2010). Barcoded Illumina sequencing 
libraries were prepared from double-stranded cDNA generated from each of the mRNA enriched 
samples, and the 10-sample pool was sequenced on one lane of an Illumina HiSeq2000 
sequencer. After barcode removal, each of the RNA-seq data sets was composed of 38-
nucleotide-long reads (3.57 ± 0.8 × 10^7/mRNA reads per sample). Transcript abundances were 
normalized for each of the 8 species in each sample to reads per million per kilobase (RPMK). 
For conserved protein domain analysis, RNA-Seq reads aligned to the genomes of the eight 
bacterial strains were categorized by conserved protein domain based on the NCBI conserved 
protein domain database on August 15, 2012.  We then performed gene set enrichment analysis 
(GSEA, Broad Institute, http://software.broadinstitute.org/gsea/index.jsp) to determine conserved 
domains that were differentially enriched in a given mouse genotype (A. Subramanian et al., 
2005). 
2.4 Enzyme-Linked ImmunoSorbent Assays (ELISA) 
Segments of proximal colon (2-3cm long) were washed, weighed, minced, and cultured for 
22 hours as described previously after which culture supernatants were stored at -80 ºC (Patwa et 
al., 2011). Mouse IL-12/23 p40 in culture supernatants was measured by ELISA as described 
previously (Patwa et al., 2011). 
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2.5 Bacterial gDNA isolation 
Luminal gDNA was isolated by incubating cecal or colonic content in 500 µL lysis buffer 
(200 mM NaCl, 100 mM Tris pH 8.0, 20 mM EDTA, 20 mg/mL lysozyme) at 37 ºC for 30 min, 
then adding 30 µL of 20% SDS and 30 µL proteinase K (20 mg/mL), and incubating at 60 ºC for 
30 min. Three hundred µL of 0.1 mm glass beads (Biospec) and 500 µL of 
phenol:chloroform:isoamyl alcohol (25:24:1, pH 8) were added and then samples were lysed in 
the TeSeE Precess48 bead beater (Bertin Technologies) for 3 rounds of 90 sec at 6200 rpm.  
After centrifugation, the aqueous layer was extracted with another 500 µL of 
phenol:chloroform:isoamyl alcohol followed by 500 µL chloroform.  The DNA in the aqueous 
phase was precipitated with ethanol, resuspended in Tris-EDTA buffer, and then further purified 
using DNeasy Mini Spin Columns according to the manufacturer’s instructions (Qiagen, 
Valencia, CA). 
2.6 Quantitative real-time PCR 
For quantitative PCR, species-specific oligonucleotide primers (detail sequence see Table 
2.1) were used to target bacterial species-specific hypervariable regions of the 16S rRNA gene. 
Twenty nanograms of bacterial gDNA was added to 8 µL of iTaq Universal SYBR Green 
Supermix (Bio-Rad, Hercules, CA) and 0.4 µM of the forward and reverse primers as indicated 
in table S1 and placed in the Applied Biosystems QuantStudio 6 Flex Real-Time PCR System 
(Applied Biosystems, Foster City, CA) running universal conditions.  Data were analyzed using 
the deltaCt method with reference to total-bacteria 16S primers. 
2.7 Generation of E. faecalis EIIA11616 and EIIgnt mutant strains 
Deletion of EIIA11616 and EIIgnt genes from E. faecalis OG1RF chromosome was 
accomplished by allelic replacement using the temperature-sensitive shuttle vector pJRS233 
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(Perez-Casal, Price, Maguin, & Scott, 1993). Deletion alleles were constructed by PCR 
amplification of upstream (US) and downstream (DS) DNA fragments (~1,000 bp each) on 
either side of EIIA11616 or EIIgnt genes using primer pairs (Table 2.2) PTSIIA-1.A-
EcoR1/PTSIIA-1.B-BamHI (US of EIIA11616), PTSII-2.A-BamHI/PTSIIA-2.B-NcoI (DS of 
EIIA11616) or uPTSXmaF/uPTSXbaR (US of EIIgnt), dPTSXbaF/dPTSSacR (DS of EIIgnt). These 
PCR products were sequentially cloned into pJRS233 shuttle vector, using standard cloning 
techniques to create pJH190 (for EIIA11616 deletion mutant) and pJH192 (for EIIgnt mutant). 
Deletion constructs were then transformed into E. faecalis OG1RF by electroporation and the 
transformants were selected at 30 °C on erythromycin (Erm). Chromosomal integrates were 
selected by growing at 42 °C in the presence of Erm. Selection for excision of the integrated 
plasmid by homologous recombination was accomplished by growing the bacteria at 30 °C in the 
absence of Erm. Erm-sensitive colonies with double-crossover events that integrated deletion 
alleles were selected by PCR screening. Deletions were confirmed by PCR and DNA 
sequencing. 
2.8 Bacterial growth assay 
Parental or mutant bacterial overnight cultures in BHI were diluted to 1.0 optical density at 
600 nm (OD600) and added (1:100 ratio) to M9 based minimal media supplemented with essential 
and non-essential amino acids (Invitrogen, Carlsbad, CA) and MEM vitamin solution 
(Invitrogen, Carlsbad, CA) and the indicated carbohydrate source. The cultures were incubated at 
37° C in aerobic or anaerobic conditions. At the specified time points, an aliquot of the culture 
was taken for OD600 measurement. 
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2.9 Biolog™ screen 
Biolog Phenotype Micro Arrays™ PM1-PM5 on E. faecalis and ΔEIIA11616 were 
performed by Biolog, Inc (Hayward, CA). PM1 contains primarily carbohydrate and carboxylate 
substrates, whereas PM2 through PM5 contain individual L-amino acids and most dipeptide 
combinations, for a total of 367 substrate nutrients. Parental and mutant EIIA11616 bacteria picked 
from colonies grown on agar plates were diluted to the same concentrations using proprietary 
minimal media and added to PM1-PM5. A proprietary redox dye was added, and the plates were 
placed in the OmniLog® automated incubator/reader for 22 hours. 
2.10 Statistical analysis 
P values were calculated using two-tailed Student's t test when two experimental groups 
were compared. All data are presented as the mean ± SEM. 
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2.11 Tables 
Table 2.1 Species-specific 16S-targeted Primers for Quantitative PCR. 
 
Target bacterial species Primer sequence (5’ -> 3’) 
Escherichia coli NC101 F: 5'- CGTGTTGTGAAATGTTGGGTTAA -3' R: 5'- CCGCTGGCAACAAAGGATAA -3' 
Lactobacillus rhamnosus GG F: 5'- GAGAAGAATGGTCGGCAGAGTAA -3' R: 5'- CACGTAGTTAGCCGTGGCTTT -3' 
Enterococcus faecalis OG1RF F: 5'- CGCGGTGCATTAGCTAGTTG -3' R: 5'- TCACCCTCTCAGGTCGGCTAT -3' 
Bacteroides thetaiotaomicron VPI-5482 F: 5'- CAGTGTCAGTTGCAGTCCAGTGA -3' R: 5'- GTGTAGCGGTGAAATGCTTAGATATC -3' 
Bacteroides vulgatus ATCC 8482 F: 5'- GGTCGCCATCGGCCTTA -3' R: 5'- CTAGCTACAGGCTTAACACATGCAA -3' 
Faecalibacterium prausnitzii A2-165 F: 5’- CCCTTCAGTGCCGCAGT -3’ R: 5’- GTCGCAGGATGTCAAGAC -3’ 
Bifidobacterium longum subsp. Infantis ATCC 15697 F: 5'- GCAACGCGAAGAACCTTACC -3' R: 5'- CGCCCCGAAGGGAAAC -3' 
Ruminococcus gnavus VPI C7-9 (ATCC 29149) F: 5'- AACGTACTCCCCAGGTGGAAT -3' R: 5'- CGGGTGGCAAAGCCATT -3' 
All bacteria universal F: 5’- GTGSTGCAYGGYTGTCGTCA -3’ R: 5’- ACGTCRTCCMCACCTTCCTC -3’ 
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Table 2.2 Primer sequence for Cloning. 
 
Primer name Primer sequence (5’ -> 3’) 
PTSIIA-1.A-EcoR1 5'- tatagaattcTCAAGTAAGCCTTTAATGGTG -3' 
PTSIIA-1.B-BamHI 5'- gcgcggatccAGAAGAAGAATTTTAGGAGG -3' 
PTSIIA-2.A-BamHI 5'- tataggatccTCACTTACTTCTTTACATAGC -3' 
PTSIIA-2.B-NcoI 5'- gcgcccatggTGGAACGTCAAGAAACGAGG -3' 
Pts2AXma 5'- tatacccgggTCAAGTAAGCCTTTAATGGTG -3' 
Pts2BXma 5'- gcgccccgggTGGAACGTCAAGAAACGAGG -3' 
uPTSXmaF 5'- tcccgggAATATAGGTCAACCCCATTGCTC -3' 
uPTSXbaR 5'- ctctagaGAATGTAGTAAAGGGTGAAAGCAATG -3' 
dPTSXbaF 5'- ctctagaAGTTCCTCCTTCTTATCCTTGGTT -3' 
dPTSSacR 5'- tccgcggGGTGCCGTCACTTTTCAAGGAA -3' 
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CHAPTER 3: RESULTS 
 
3.1 Inflammation is associated with altered bacterial transcription in mice colonized with 
complex microbiota 
Previous work has identified colitis-associated transcriptome profiles of bacteria from 
mono-colonized mice (Arthur et al., 2014; Patwa et al., 2011). To address the effects of intestinal 
inflammation on commensal microbes in a more complex luminal environment, we selectively 
colonized GF WT and Il10-/- mice with a mixture of eight bacterial strains representing each of 
the major phyla found in the mammalian colon. We chose these particular strains because the 
genomic sequences are known, which facilitates the analysis of transcriptional data sets, and 
because many of them have been implicated in human IBDs or experimental colitis. 
We found that histological inflammation was greater in Il10-/- mice compared to WT mice 
at both 5 and 10 weeks’ post-colonization and that inflammation in Il10-/- mice was greater at 10 
weeks than at 5 weeks (Figure 3.1A). Similar to the histological inflammation, we detected 
increased IL-12/23 p40 secretion by colon tissue explants from Il10-/- vs. WT mice colonized 
with the bacterial mixture for both 5 and 10 weeks (Figure 3.1B). 
We next wanted to determine whether colitis in the 10-week colonized mice is associated 
with altered bacterial function.  To assess function, we first measured global transcriptional 
activity of each bacterial strain using microbial RNA-Sequencing (RNA-seq) technology. The 
largest number of ≥1.5-fold differentially expressed genes is found in E. faecalis (Table 3.3 and 
3.4) followed by R. gnavus, B. vulgatus, and B. thetaiotaomicron (Figure 3.2). We performed a 
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principal components analysis and found that the bacterial meta-transcriptome in Il10-/- mice is 
different from that in WT mice (Figure 3.3). We next used conserved domain analysis to 
determine which of the known protein domains are significantly enriched in Il10-/- and WT mice. 
In bacteria from Il10-/- mice with colitis, we detected enrichment of transcripts that encode 
protein domains important in transcription/translation, cell wall synthesis, anaerobic metabolism, 
carbohydrate metabolism, stress responses, and DNA repair (Table 3.1). In bacteria from healthy 
WT mice, we detected enrichment of transcripts that encode protein domains important in redox 
potential maintenance, iron uptake, cation transport, and cell signaling (Table 3.2). Four out of 
10 enriched conserved protein domains we detected from Il10-/- mice are involved with 
carbohydrate metabolism. This suggests that the carbohydrate landscape in the lumen of the 
inflamed colon differs from that in the non-inflamed colon and/or that metabolism of 
carbohydrates by luminal bacteria is impacted by colitis. 
 Since the largest number of differentially expressed genes in our model system is found in 
E. faecalis and colitis impacts bacterial carbohydrate metabolism in general, we predicted that 
many of the differentially expressed genes in E. faecalis would involve carbohydrate 
metabolism. Indeed, the E. faecalis PTS operon including OG1RF_11616 was the most highly 
upregulated set of genes in E. faecalis during colitis (Table 3.3). Another E. faecalis PTS operon 
including OG1RF_12399 was also highly upregulated during colitis (Table 3.3). PTS couple the 
transport of sugars across the cytoplasmic membrane with their phosphorylation so that they can 
be used as a carbon source for metabolism. PTS also serve as signal transduction systems that 
monitor carbohydrate utilization and control other carbohydrate metabolic processes based on 
the flux of phosphate through the pathway. We hypothesized that the carbohydrate substrates for 
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these two E. faecalis PTS operons may contribute to experimental colitis and therefore sought to 
identify them. 
3.2 The substrates for PTS EIIA11616 and EII12399 
To determine the substrates of the PTS encoded by the OG1RF_11616 and OG1RF_12399 
operons, we first created two mutant strains of E. faecalis (E. faecalis ∆EIIA11616 and E. faecalis 
∆EII12399). We then tested growth of the mutant and parental strains in minimal media containing 
fructose, mannose or sorbose as the sole carbon source since these sugars are putative candidates 
based on the NCBI annotation of these operons. There was no growth difference between 
parental and mutant E. faecalis in M9 minimal media supplemented with fructose or mannose 
(Figure 3.4A and B), and none of strains grew in media containing sorbose (Figure 3.4C). 
Therefore, we conclude that fructose, mannose, and sorbose are not substrates for the PTS 
encoded by either of these PTS operons. 
We then performed a dedicated sequence alignment of genes in the OG1RF_11616 operon 
with bacterial genes in the NCBI prokaryotic database and found sequence similarity between 
certain genes in this operon and genes in the database that were annotated as glucosamine-
fructose-6-phosphate aminotransferase. Therefore, we repeated the growth assays in minimal 
media supplemented with glucosamine and found that mutant E. faecalis ∆EIIA11616 has a slight 
growth deficit compared to parental strain (Figure 3.4D). Therefore, the PTS encoded by the 
OG1RF_11616 operon facilitates, but is not necessary for, glucosamine utilization. 
Because our targeted approach did not clearly establish the substrate used by the PTS 
encoded by the OG1RF_11616 operon, we performed a high-throughput screen by growing E. 
faecalis ∆EIIA11616 and parental E. faecalis OG1RF on a large variety of substrates in the Biolog 
Phenotype Microarray System, which measures the ability of bacteria to use substrates to 
 20 
produce reducing substances including NADH.  The screen showed that parental and mutant E. 
faecalis ∆EIIA11616 strains had similar metabolic activity on most substrates.  However, potential 
differences in metabolic activity between the two strains were detected for five substrates: 
gluconic acid, glucosaminic acid, frucotose-6-phosphate, inosine and dulcitol (Figure 3.5). To 
determine whether the OG1RF_11616 operon encodes proteins that permit E. faecalis to use 
these five substrates for growth, we tested whether E. faecalis ∆EIIA11616 could grow in minimal 
media supplemented with these carbohydrates. We found that both strains grow similarly in 
glucosaminic acid and frucotose-6-phosphate, and neither strain grows in dulcitol. Interestingly, 
mutant E. faecalis ∆EIIA11616 grows better than the parental strain in gluconic acid. Neither strain 
grows efficiently in inosine-supplemented media, but the parental E. faecalis OG1RF does have 
a slight growth advantage over E. faecalis ∆EIIA11616 (Figure 3.6B). 
In addition to the five substrates identified as strong candidates in the Biolog screen, we 
also observed weaker effects of the nucleosides thymidine, uridine, and adenosine on 
OG1RF_11616-mediated metabolism in the Biolog screen (Figure 3.5). Neither E. faecalis 
OG1RF nor E. faecalis ∆EIIA11616 grows efficiently in adenosine or uridine, but E. faecalis 
OG1RF does have a slight growth advantage (Figure 3.6). Since ribose is a shared component of 
nucleosides, we predicted that the OG1RF_11616 operon might encode genes that metabolize 
ribose. To test this, we performed growth assays in minimal media plus ribose and found that 
parental E. faecalis OG1RF grows slightly better than E. faecalis ∆EIIA11616 (Figure 3.6A). 
Similar to the data for glucosamine, these data suggest that gene products of the OG1RF_11616 
operon facilitate, but are not required for, ribose metabolism. 
Without having clearly identified the substrate for the PTS encoded by the OG1RF_11616 
operon, we then turned our attention to identifying the substrate for the PTS encoded by the 
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OG1RF_12399 operon. We found that EII12399 shares amino acid sequence similarity with the E. 
faecalis V583 EF3136 gene, which has been suggested by others to transport gluconate. To test 
whether the proteins encoded by the OG1RF_12399 operon also transport gluconate, we grew 
parental and mutant E. faecalis ∆EII12399 in M9 minimal media supplemented with sodium 
gluconate as a sole carbon source. Parental E. faecalis OG1RF grows efficiently in gluconate-
containing media, but E. faecalis ∆EII12399 fails to grow thus confirming that the PTS encoded by 
the OG1RF_12399 operon transports gluconate and is necessary for gluconate utilization by E. 
faecalis OG1RF (Figure 3.7). Therefore, we designate PTS EII12399 as PTS EIIgnt. 
3.3 E. faecalis PTS genes are associated with increased inflammation in Il10-/- mice 
Though the effects of inflammation on luminal gluconate, ribose, and glucosamine 
concentrations in the intestine are unknown, we sought to determine whether E. faecalis genes 
that encode proteins that participate in metabolism of these carbohydrates affect the severity of 
chronic experimental colitis. We hypothesized that E. faecalis upregulates PTS OG1RF_11616 
and 12399 operons during inflammation to utilize carbohydrates present in the inflamed colon, 
enhance E. faecalis growth, and worsen colitis. 
To test our hypothesis, we colonized GF WT and Il10-/- mice with E. faecalis (either 
mutant ∆EIIA11616 or parental E. faecalis OG1RF) plus the seven other bacteria in our 
previously-described bacteria consortium. We found no histological inflammation in WT mice 
regardless of bacterial strain (Figure 3.8A). There is a trend toward more histological 
inflammation in Il10-/- mice colonized for four weeks with the parental E. faecalis compared with 
E. faecalis ∆EIIA11616 (Figure 3.8A). The difference was statistically significant after eight 
weeks of colonization (Figure 3.8A). Spontaneous secretion of IL-12/23 p40 by colonic explants 
from these mice generally parallels the severity of histological inflammation though differences 
 22 
in IL-12/23 p40 secretion between parental E. faecalis OG1RF and E. faecalis ∆EIIA11616 were 
statistically significant at four weeks after colonization (Figure 3.9). These data suggest that the 
presence of EIIA11616 in E. faecalis promotes colitis in this model.  
Similar to the E. faecalis ∆EIIA11616 experiment, we also colonized GF WT and Il10-/- mice 
with E. faecalis (either mutant E. faecalis ∆EIIgnt or parental E. faecalis OG1RF) plus the seven 
other bacterial strains in our previously-described bacterial consortium. After five weeks of 
colonization, Il10-/- mice colonized with parental E. faecalis have significantly more histological 
inflammation and IL-12/23 p40 secretion from colon explants than Il10-/- mice colonized with E. 
faecalis ∆EIIgnt (Figure 3.10 and 3.11). However, after ten weeks of colonization, the differences 
in histological inflammation and IL-12/23 p40 secretion between the two groups of mice are 
absent (Figure 3.10 and 3.11). These data suggest that colonization with PTS EIIgnt-expressing E. 
faecalis accelerates the onset of experimental colitis in Il10-/- mice, but does not affect the colitis 
severity at later time points. 
 We next hypothesized that the decreased colitis severity in Il10-/- mice colonized with E. 
faecalis ∆EIIgnt or E. faecalis ∆EIIA11616 is due to decreased luminal survival of the mutant 
strains relative to the parental strain. To test this, we determined the abundance of E. faecalis in 
cecal contents from the colonized mice using E. faecalis-specific 16S primers and real-time 
qPCR. There are similar proportions of parental and mutant E. faecalis ∆EIIA11616 or E. faecalis 
∆EIIgnt in the cecal contents of Il10-/- mice with colitis (Figure 3.12). This suggests that neither 
PTS EIIA11616 or PTS EIIgnt confer a survival advantage to luminal E. faecalis during 
inflammation. However, we observed that the relative abundances of Bacteroides species (B. 
thetaiotaomicron and B. vulgatus) are significantly decreased in Il10-/- mice colonized with 
parental E. faecalis compared with mutant E. faecalis ∆EIIA11616 or E. faecalis ∆EIIgnt (Figure 
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3.12). R. gnavus is also significantly decreased in Il10-/- mice colonized with parental E. faecalis 
compared with E. faecalis EIIgnt (Figure 3.12B). Further, we observed that the relative 
abundances of B. longum and B. thetaiotaomicron are significantly decreased in WT mice 
colonized with parental E. faecalis compared with mutant E. faecalis ∆EIIA11616 (Figure 3.13). 
These data suggest that E. faecalis PTS EIIA11616 and E. faecalis PTS EIIgnt may compete for 
nutrients used by Bacteroides species for growth and/or survival during experimental colitis 
development. 
3.4 The pro-inflammatory potential of EIIA11616 requires the presence of Bacteroides 
Our data demonstrate that Il10-/- mice colonized with a mixture of bacteria that includes 
PTS-deficient E. faecalis is associated with attenuated colitis compared with a mixture of 
bacteria that includes the parental E. faecalis. This suggests that the presence of PTS EIIA11616 
and EIIgnt in E. faecalis promotes colitis. However, the mechanisms of how these two E. faecalis 
PTS promote experimental colitis are unclear. First, we tried to determine whether these operons 
enhance colitis directly through E. faecalis or indirectly through other bacteria. To determine 
whether PTS EIIA11616 exerts its pro-colitogenic effect independently of other bacteria, we 
mono-colonized GF Il10-/- mice with E. faecalis ∆EIIA11616 or parental E. faecalis. Since no 
other bacteria are present in this system, then any observed differences in inflammation would 
presumably be solely due to the effects of PTS EIIA11616 on E. faecalis. We chose to evaluate 
colonic inflammation of these mono-colonized mice at a later timepoint (20 weeks) than we did 
the oct-colonized mice referenced above (8-10 weeks) because the kinetics of inflammation in E. 
faecalis-monocolonized Il10-/- mice is known to be slower compared with mice mono-colonized 
with other bacterial strains, such as E. coli NC101(Kim et al., 2005). We found that PTS 
EIIA11616 is not associated with increased histological inflammation and IL-12/23 p40 secretion 
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in E. faecalis mono-colonized Il10-/- mice at 10 weeks or 20 weeks (Figure 3.14). We also found 
no statistically significant difference in luminal concentration of bacteria in colons of mice 
mono-colonized with E. faecalis or E. faecalis ∆EIIA11616 (Figure 3.15). Together these results 
indicate that the pro-inflammatory qualities of E. faecalis PTS EIIA11616 require the presence of 
other bacterial species. Since we previously observed that the presence of E. faecalis PTS 
EIIA11616 and EIIgnt is associated with lower numbers of Bacteroides species in the oct-colonized 
mice (Figure 3.11), we hypothesized that these two E. faecalis PTS operons exert their pro-
colitogenic effects via Bacteroides species in the colon lumen. To determine whether the 
presence of Bacteroides species is necessary for the E. faecalis PTS EIIA11616-mediated 
increased colitis observed in oct-colonized Il10-/- mice (Figures 3.8 and 3.9), we repeated 
experiments described in Figures 3.8 and 3.9, but omitted the two Bacteroides species from the 
colonizing inoculum. In the absence of the two Bacteroides species, we found that the presence 
of E. faecalis PTS EIIA11616 has no effect on the severity of histological colon inflammation or 
levels of IL-12/23 p40 secretion (Figure 3.16). Therefore, we conclude that Bacteroides species 
are required for E. faecalis PTS EIIA11616-mediated colitis. 
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3.5 Figures 
 
  
  
Figure 3.1 Spontaneous intestinal inflammation develops in Il10-/- mice colonized with a 
defined mixture of intestinal bacteria. Germ free WT and Il10-/- mice were colonized with 8 
microbes (Enterococcus faecalis, Ruminococcus gnavus, Faecalibacterium prausnitzii, 
Lactobacillus rhamnosus, Bacteroides thetaiotaomicron, Bacteroides vulgatus, Bifodobacterium 
longum, and Escherichia coli) for 5 and 10 weeks. (A) Sum of blinded histological inflammation 
scores of four segments of colon from each mouse. (B) IL-12/23 p40 concentrations in culture 
supernatants from colonic tissue explant cultures normalized per mg of tissue. Data are presented 
as mean ± standard error of mean, n = 4 - 5 mice/group. ** p < 0.01 versus WT. 
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Figure 3.2 Number of differentially expressed microbial genes between WT and Il10-/- mice 
colonized with a defined mixture of intestinal bacteria. Bacterial RNA was isolated from 
cecal contents from the 10-week-colonized WT and Il10-/- mice described in the legend to Figure 
3.1. Bacterial gene expression was determined using microbial RNA-seq and GeneSpring GX 
software. For the species that had at least one differentially expressed gene, we present the 
number of genes with ≥ 1.5-fold change in gene expression (WT vs. Il10-/-) with an FDR-
corrected p value of ≤ 0.05. 
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Figure 3.3 Colitis is associated with an altered luminal bacterial meta-transcriptome. 
Principal component analysis of the luminal bacterial gene expression profiles of ten-week-
colonized WT and Il10-/- mice described in the legend to Figure 3.1. 
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Figure 3.4 Growth curves of parental and mutant E. faecalis strains in minimal media 
supplemented with selected carbon sources. Parental E. faecalis (Ef), E. faecalis ∆ EIIA11616 
(Ef ∆ EIIA11616), and E. faecalis ∆EII12399 (Ef ∆EII12399) were grown aerobically in minimal 
media supplemented with the indicated sole carbon source (A) 0.5 % fructose, (B) 0.5% 
mannose, (C) 0.5% sorbose, and (D) 0.4% glucosamine. 
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Figure 3.5 High throughput metabolic screen of E. faecalis and E. faecalis ∆EIIA11616 
strains grown in the presence of various sole carbon sources. Output from one representative 
Phenotype Micro Array™ PM1, which predominantly includes carbohydrate and carboxylate 
substrates as carbon sources. Each well in the 96-well plate contains a unique carbon source.  
Each plot in the 96 cells depicted above presents dye reduction (i.e. metabolic activity) on the Y-
axis and time on the X-axis (0-16 hours).  Red areas represent times at which the parental strain 
metabolizes the carbon source better than the mutant strain and green areas represent times at 
which the mutant strain metabolizes the carbon source better than the parental strain. Cells with 
apparent differences in metabolism of the carbon source between the two strains are highlighted. 
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Figure 3.6 The presence of PTS EIIA11616 is associated with increased E. faecalis growth 
minimal media containing ribose and nucleosides as the sole carbon source. Growth curves 
of parental E. faecalis (Ef) and E. faecalis ∆ EIIA11616 (Ef ∆ EIIA11616) grown in minimal media 
supplemented with the following sole carbon sources (A) 0.5 % ribose, (B) 0.5% inosine, (C) 
0.5% uridine, and (D) 0.1% adenosine under aerobic conditions. 
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Figure 3.7 PTS EII12399 is essential for gluconate utilization by E. feacalis. Parental E. 
faecalis (Ef), E. faecalis ∆ EIIA11616 (Ef ∆ EIIA11616), and E. faecalis ∆EII12399 (Ef ∆EII12399) 
were grown in minimal media supplemented with sodium gluconate as the sole carbon source.  
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Figure 3.8 PTS EIIA11616 is associated with increased histological colon inflammation in 
Il10-/- mice. WT and Il10-/- mice were colonized with seven intestinal bacterial species identified 
in the legend of Figure 3.1 plus either parental E. faecalis or E. faecalis ∆EIIA11616 for 4 or 8 
weeks. (A) Sum of blinded histological inflammation scores of four colon segments. Data are 
presented as mean ± standard error of mean, n = 4 - 6 mice/group. *p < 0.05 versus parental E. 
faecalis group. Representative photomicrographs of H & E stained colon tissue from Il10-/- mice 
colonized for eight weeks with bacterial mixture that includes (B) parental E. faecalis or (C) E. 
faecalis ∆EIIA11616. 
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Figure 3.9 PTS EIIA11616 is associated with increased IL-12/23 p40 secretion by colon 
explants from Il10-/- mice. WT and Il10-/- mice were colonized as described in the legend to 
Figure 3.8. IL-12/23 p40 concentrations in colonic tissue explant culture supernatants were 
normalized per mg tissue weight. Data are presented as mean ± standard error of mean, n = 4 - 6 
mice/group. * p < 0.05 versus parental E. faecalis group. 
  
P M P M P M P M
0
50
100
150
200
IL
-1
2/
23
 p
40
 (p
g/
m
g 
tis
su
e)
4 weeks 8 weeks 4 weeks 8 weeks
WT Il10-/-
P: E. faecalis + 7 bacteria
M: E. faecalis ΔEIIA11616 + 7 bacteria
*
*
 34 
  
 
Figure 3.10 PTS EIIgnt is associated with increased histological colon inflammation in Il10-/- 
mice. WT and Il10-/- mice were colonized with seven bacterial species identified in the legend to 
Figure 3.1 plus either parental E. faecalis or E. faecalis ∆EIIgnt for five or ten weeks. (A) Sum of 
blinded histological inflammation scores of four colon segments. Data are presented as mean ± 
standard error of mean, n = 5 - 6 mice/group. * p < 0.05 versus parental E. faecalis group. 
Representative photomicrographs of H & E stained colon tissue from Il10-/- mice colonized for 
five weeks with bacterial mixture that includes (B) parental E. faecalis or (C) E. faecalis ∆EIIgnt. 
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Figure 3.11 PTS EIIgnt is associated with increased IL-12/23 p40 secretion by colon explants 
from Il10-/- mice. WT and Il10-/- mice were colonized as described in the legend to Figure 3.10. 
IL-12/23 p40 concentrations in colonic tissue explant culture supernatants normalized per mg 
tissue weight. Data are presented as mean ± standard error of mean, n = 5 - 6 mice/group. * p < 
0.05 versus parental E. faecalis group. 
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Figure 3.12 PTS EIIA11616 and EIIgnt are associated with an altered luminal bacterial 
composition in Il10-/- mice. (A) Relative abundance of eight bacterial species in cecal contents 
from Il10-/- mice colonized for eight weeks as described in the legend to Figure 3.8 as measured 
by real-time PCR relative to universal 16S. n = 6 mice/group. (B) Relative abundance of eight 
bacterial species in cecal contents from Il10-/- mice colonized for five weeks as described in the 
legend to Figure 3.10 as measured by real-time qPCR relative to universal 16S. n = 5 - 6 
mice/group. Data are presented as mean ± standard error of mean.  * p < 0.05 versus parental E. 
faecalis group. ** p < 0.01 versus parental E. faecalis group. 
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Figure 3.13 PTS EIIA11616 is associated with an altered luminal bacterial composition in 
WT mice. (A) Relative abundance of eight bacterial species in cecal contents from WT mice 
colonized for eight weeks as described in the legend to Figure 3.8 as measured by real-time PCR 
relative to universal 16S. n = 6 mice/group. Data are presented as mean ± standard error of mean.  
* p < 0.05 versus parental E. faecalis group. 
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Figure 3.14 PTS EIIA11616 does not affect colitis severity in E. faecalis mono-colonized Il10-/- 
mice. Il10-/- mice were mono-colonized with parental E. faecalis or E. faecalis ∆EIIA11616 for 10 
and 20 weeks. (A) Sum of blinded histological inflammation scores of four colon segments. (B) 
IL-12/23 p40 concentrations in colonic tissue explant culture supernatants normalized per mg 
tissue weight. Data are presented as mean ± standard error of mean, n = 5 - 6 mice/group, ns: not 
significant. 
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Figure 3.15 PTS EIIA11616 does not affect luminal E. faecalis concentration in E. faecalis 
mono-colonized Il10-/- mice. Luminal E. faecalis concentrations in Il10-/- mice mono-colonized 
for 10 and 20 weeks with either parental E. faecalis or E. faecalis ∆EIIA11616. Data are presented 
as mean ± standard error of mean, n = 5 - 6 mice/group, ns: not significant. 
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Figure 3.16 E. faecalis PTS EIIA11616 does not affect colitis severity in the absence of 
Bacteroides species. Il10-/- mice were colonized for ten weeks with parental E. faecalis or E. 
faecalis ∆EIIA11616 plus the five non-Bacteroides species described in the legend to Figure 3.1 
(R. gnavus, F. prausnitzii, L. rhamnosus, B. longum, and E. coli). (A) Sum of blinded 
histological inflammation scores of four colon segments. (B) IL-12/23 p40 concentrations in 
colonic tissue explant culture supernatants normalized per mg tissue weight. Data are presented 
as mean ± standard error of mean, n = 7 - 8 mice/group, ns: not significant. 
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3.6 Tables 
Table 3.1 Conserved protein domains significantly enriched in luminal bacteria from Il10-/- 
vs. WT mice colonized for ten weeks with a mixture of intestinal bacterial species. 
 
Score Conserved Domain FDR q value 
2.12 Amino-acyl tRNA Synthetase 0.001 
2.05 Translation Factor-II-Like 0.002 
1.92 Mur Ligase Family 0.011 
1.90 Phosphoribosyl Transferase Domain 0.013 
1.87 Sugar Transferase 0.015 
1.86 Glycyl Radical Superfamily 0.017 
1.83 PTS Regulation Domain 0.019 
1.83 Cold Shock Domain 0.018 
1.77 GH18 Chitinase-Like Superfamily 0.034 
1.71 MutL Transducer Domain 0.053 
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Table 3.2 Conserved protein domains significantly enriched in luminal bacteria from WT 
vs. Il10-/- colonized for ten weeks with a mixture of intestinal bacterial species. 
 
Score Conserved Domain FDR q value 
1.92 Thioredoxin Family 0.052 
1.92 ATPase Superfamily 0.040 
1.79 Iron Dicitrate Transport 0.099 
1.70 Inorganic Cation Transporter 0.155 
1.62 Two-component Regulator Proteins 0.218 
1.61 Nitro-FMN Reductase Superfamily 0.204 
1.59 Pyridine Nucleotide-Disulfide Oxidoreductase 0.215 
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Table 3.3 Significantly upregulated genes in cecal E. faecalis OG1RF from Il10-/- vs. WT 
mice colonized with eight bacterial species for 10 weeks  
 
Gene_ID	 Fold	Change	 Product	
OG1RF_11616	 27.09	 PTS	family	mannose/fructose/sorbose	porter	component	IIA	
OG1RF_11614	 13.35	 PTS	family	mannose/fructose/sorbose	porter	component	IIC	
OG1RF_11613	 12.60	 PTS	family	mannose/fructose/sorbose	porter	component	IID	
OG1RF_11612	 11.87	 phosphosugar-binding	protein	
OG1RF_11611	 10.48	 phosphosugar	isomerase	
OG1RF_11615	 11.36	 PTS	family	ascorbate	porter,	IIB	component	
OG1RF_11610	 6.29	 hypothetical	protein	
OG1RF_10367	 5.19	 decarboxylase	
OG1RF_10369	 4.83	 Na+/H+	antiporter	NhaC	
OG1RF_12405	 4.56	 6-phosphogluconate	dehydrogenase	
OG1RF_12398	 4.54	 mannonate	dehydratase	
OG1RF_10368	 4.61	 amino	acid	permease	
OG1RF_12403	 4.11	 putative	glycerol	dehydrogenase	
OG1RF_12182	 4.04	 acetyl-CoA	carboxylase	biotin	carboxyl	carrier	subunit	
OG1RF_12402	 3.67	 PTS	family	mannose/fructose/sorbose	porter	component	IIC	
OG1RF_12404	 3.51	 D-isomer	specific	2-hydroxyacid	dehydrogenase	
OG1RF_12397	 3.78	
2-dehydro-3-deoxyphosphogluconate	aldolase/4-hydroxy-2-
oxoglutarate	aldolase	
OG1RF_12544	 3.41	 sporulation	initiation	inhibitor	protein	Soj	
OG1RF_12399	 3.54	 PTS	family	mannose/fructose/sorbose	porter	component	IIA	
OG1RF_10430	 3.30	 RpiR	family	phosphosugar-binding	transcriptional	regulator	
OG1RF_12401	 3.48	 PTS	family	mannose/fructose/sorbose	porter	component	IID	
OG1RF_10851	 3.68	 UDP-glucose--hexose-1-phosphate	uridylyltransferase	
OG1RF_12080	 2.91	 ribosomal	protein	L7/L12	
OG1RF_10166	 3.10	 50S	ribosomal	protein	L6	
OG1RF_10164	 3.18	 ribosomal	protein	S14p/S29e	
OG1RF_12179	 3.33	 acetyl-coA	carboxylase	carboxyl	transferase	subunit	beta	
OG1RF_10178	 3.03	 50S	ribosomal	protein	L17	
OG1RF_11167	 2.71	 alanine--tRNA	ligase	
OG1RF_10165	 2.98	 30S	ribosomal	protein	S8	
OG1RF_10853	 3.00	 hypothetical	protein	
OG1RF_10216	 2.78	 6-phospho-beta-glucosidase	
OG1RF_11810	 2.83	 amino	acid	permease	
OG1RF_11283	 2.96	 chorismate	synthase	
OG1RF_10152	 2.74	 ribosomal	protein	L4/L1	family	protein	
OG1RF_12331	 2.73	 secreted	lipase	
OG1RF_10177	 2.73	 DNA-directed	RNA	polymerase	subunit	alpha	
OG1RF_10753	 2.82	 6-phospho-beta-glucosidase	
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OG1RF_10893	 2.75	 phenylalanyl-tRNA	synthetase	alpha	subunit	
OG1RF_12400	 2.84	 PTS	family	mannose/fructose/sorbose	porter,	IIB	component	
OG1RF_10159	 2.56	 50S	ribosomal	protein	L29	
OG1RF_10217	 2.58	 phosphoglycerate	mutase	
OG1RF_11875	 2.55	 acyl-CoA	thioester	hydrolase	
OG1RF_10559	 2.60	 BglG	family	transcriptional	antiterminator	
OG1RF_10175	 2.52	 30S	ribosomal	protein	S13	
OG1RF_11938	 2.48	 fumarate	reductase	
OG1RF_10281	 2.38	 secreted	antigen	
OG1RF_10162	 2.45	 50S	ribosomal	protein	L24	
OG1RF_10638	 2.41	 ABC	superfamily	ATP	binding	cassette	transporter,	ABC	protein	
OG1RF_10894	 2.47	 phenylalanyl-tRNA	synthetase	beta	subunit	
OG1RF_12406	 2.47	 RpiR	family	phosphosugar-binding	transcriptional	regulator	
OG1RF_10637	 2.44	
oligopeptide	ABC	superfamily	ATP	binding	cassette	transporter,	
membrane	protein	
OG1RF_10660	 2.54	 ATP-dependent	DNA	helicase	
OG1RF_10208	 2.38	 hypoxanthine	phosphoribosyltransferase	
OG1RF_10636	 2.41	
oligopeptide	ABC	superfamily	ATP	binding	cassette	transporter,	
membrane	protein	
OG1RF_10084	 2.45	 cell	wall	surface	anchor	protein	
OG1RF_11285	 2.42	 3-phosphoshikimate	1-carboxyvinyltransferase	
OG1RF_10736	 2.23	 isoleucine--tRNA	ligase	
OG1RF_10752	 2.38	 PTS	family	lactose/cellobiose	(lac)	porter	component	IIC	
OG1RF_10147	 2.26	 elongation	factor	EF1A	
OG1RF_10671	 2.33	 extracellular	protein	
OG1RF_11839	 2.19	 glycyl-tRNA	synthetase	beta	subunit	
OG1RF_10807	 2.19	 glutathione	S-transferase	
OG1RF_11330	 2.26	 DNA	topoisomerase	(ATP-hydrolyzing)	subunit	A	
OG1RF_12180	 2.33	 acetyl-CoA	carboxylase	subunit	A	
OG1RF_12231	 2.21	 valine--tRNA	ligase	
OG1RF_10286	 2.22	 membrane	protein	
OG1RF_11022	 2.12	 ABC	superfamily	ATP	binding	cassette	transporter,	binding	protein	
OG1RF_11840	 2.13	 glycyl-tRNA	synthetase	alpha	subunit	
OG1RF_12543	 2.15	 plasmid	partition	ParB	protein	
OG1RF_12311	 2.07	
peptide	ABC	superfamily	ATP	binding	cassette	transporter,	binding	
protein	
OG1RF_10657	 2.08	 methionine--tRNA	ligase	
OG1RF_10207	 2.07	 tRNA(Ile)-lysidine	synthase	(tRNA(Ile)-lysidinesynthetase)	
OG1RF_11602	 2.03	 putative	calcium-transporting	ATPase	
OG1RF_11607	 1.95	 membrane-oligosaccharide	glycerophosphotransferase	
OG1RF_11714	 1.98	 group	2	glycosyl	transferase	
OG1RF_12322	 2.05	 hypothetical	protein	
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OG1RF_10452	 1.86	 trigger	factor	
OG1RF_12485	 1.97	
phosphatidylglycerol--membrane-oligosaccharide	
glycerophosphotransferase	
OG1RF_12541	 1.89	 GTP-binding	protein	YchF	
OG1RF_11573	 1.90	 UDP-N-acetylmuramate--L-alanine	ligase	
OG1RF_11715	 1.87	 glycosyltransferase	
OG1RF_11818	 1.78	 proline--tRNA	ligase	
OG1RF_10337	 1.79	 AMP-binding	family	protein	
OG1RF_11718	 1.82	 hypothetical	protein	
OG1RF_12385	 1.73	 serine/threonine	protein	phosphatase	1	
OG1RF_10142	 1.75	 resolvase	family	site-specific	recombinase	
OG1RF_12493	 1.76	 DNA-directed	RNA	polymerase	subunit	beta	
OG1RF_12141	 1.73	 galactose-1-phosphate	uridylyltransferase	
OG1RF_11667	 1.74	 AraC	family	transcriptional	regulator	
OG1RF_11136	 1.74	 neopullulanase	
OG1RF_10115	 1.74	 GMP	synthase	(glutamine-hydrolyzing)	
OG1RF_11711	 1.73	 CDP-glycerol:poly(glycerophosphate)	glycerophosphotransferase	
OG1RF_11192	 1.70	 DNA	mismatch	repair	protein	MutS	
OG1RF_12150	 1.68	 5-formyltetrahydrofolate	cyclo-ligase	
OG1RF_11694	 1.67	 ABC	superfamily	ATP	binding	cassette	transporter,	ABC	protein	
OG1RF_10714	 1.64	 exodeoxyribonuclease	VII	small	subunit	
OG1RF_11417	 1.63	 aminotransferase	
OG1RF_10001	 1.60	 ATPase	
OG1RF_10958	 1.64	 Ser/Thr	protein	phosphatase	
OG1RF_10923	 1.63	 DNA-directed	RNA	polymerase	sigma	subunit	RpoE	
OG1RF_11724	 1.58	 group	2	glycosyl	transferase	
OG1RF_10459	 1.60	 NAD-dependent	DNA	ligase	LigA	
OG1RF_11713	 1.63	 CDP-glycerol:poly(glycerophosphate)	glycerophosphotransferase	
OG1RF_11449	 1.59	 tyrosine--tRNA	ligase	
OG1RF_11300	 1.56	 transketolase	
OG1RF_11819	 1.57	 RIP	metalloprotease	RseP	
OG1RF_11977	 1.55	 transcription	antiterminator	LicT	
OG1RF_10212	 1.54	 lysine--tRNA	ligase	
OG1RF_12528	 1.56	 U32	family	peptidase	
OG1RF_11731	 1.54	 dTDP-4-dehydrorhamnose	reductase	
OG1RF_10209	 1.54	 cell	division	protein	FtsH	
OG1RF_10257	 1.52	 septation	ring	formation	regulator	EzrA	
OG1RF_10002	 1.51	 DNA-directed	DNA	polymerase	III	beta	subunit	
OG1RF_11467	 1.52	 ABC	superfamily	ATP	binding	cassette	transporter,	ABC	protein	
OG1RF_10184	 1.52	 ABC	superfamily	ATP	binding	cassette	transporter,	membrane	protein	
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Table 3.4 Significantly down-regulated genes in cecal E. faecalis OG1RF from Il10-/- vs. 
WT mice colonized with eight bacterial species for 10 weeks  
 
Gene_ID	 Fold	Change	Product	
OG1RF_11321	 4.85	 hypothetical	protein	
OG1RF_12506	 3.40	 cell	wall	surface	anchor	family	protein	
OG1RF_10861	 3.52	 hypothetical	protein	
OG1RF_12156	 3.16	 hypothetical	protein	
OG1RF_10317	 3.21	
TRAP-T	family	tripartite	ATP-independent	periplasmic	transporter,	
membrane	protein	
OG1RF_10278	 3.03	 N-isopropylammelide	isopropylaminohydrolase	
OG1RF_10277	 3.05	 UIT9	family	protein	
OG1RF_10541	 2.93	 transglycosylase-associated	protein	
OG1RF_10834	 3.11	 hypothetical	protein	
OG1RF_10396	 2.80	 hypothetical	protein	
OG1RF_11643	 2.85	 universal	stress	protein	
OG1RF_11140	 2.76	 magnesium-importing	ATPase	
OG1RF_10073	 2.69	 transglycosylase	associated	protein	
OG1RF_12499	 2.73	 chitin	binding	protein	
OG1RF_10755	 2.70	 hypothetical	protein	
OG1RF_10599	 2.86	 cro/CI	family	transcriptional	regulator	
OG1RF_11929	 2.82	 hypothetical	protein	
OG1RF_10273	 2.76	 major	facilitator	family	transporter	
OG1RF_10276	 2.67	 ureidoglycolate	dehydrogenase	
OG1RF_10259	 2.72	 response	regulator	
OG1RF_11077	 2.63	 co-chaperone	GrpE	
OG1RF_10072	 2.53	 stress	response	regulator	Gls24	
OG1RF_11076	 2.57	 heat-inducible	transcription	repressor	HrcA	
OG1RF_11180	 2.51	 hypothetical	protein	
OG1RF_10845	 2.44	 VOC	metalloenzyme	family	protein	
OG1RF_11163	 2.64	 hypothetical	protein	
OG1RF_10274	 2.50	 carbamate	kinase	
OG1RF_10272	 2.50	 hypothetical	protein	
OG1RF_10268	 2.38	 hypothetical	protein	
OG1RF_10862	 2.37	 hypothetical	protein	
OG1RF_12016	 2.34	 diacylglycerol	kinase	catalytic	domain	protein	
OG1RF_11437	 2.41	 cold	shock	protein	CspA	
OG1RF_11383	 2.29	 putative	NADPH:quinone	reductase	
OG1RF_10069	 2.29	 hypothetical	protein	
OG1RF_10070	 2.29	 hypothetical	protein	
OG1RF_10820	 2.31	 LytR	family	response	regulator	
OG1RF_10090	 2.37	 putative	lipoprotein	
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OG1RF_10071	 2.25	 stress	response	regulator	Gls24	
OG1RF_11409	 2.25	 NADPH-dependent	FMN	reductase	domain	protein	
OG1RF_12346	 2.19	 cell	wall	surface	anchor	family	protein	
OG1RF_10003	 2.25	 S4	domain	protein	YaaA	
OG1RF_10068	 2.15	 3-oxoacyl-[acyl-carrier-protein]	reductase	
OG1RF_10375	 2.14	 hypothetical	protein	
OG1RF_10025	 2.13	 phosphosugar-binding	transcriptional	regulator	
OG1RF_11324	 2.18	 cardiolipin	synthetase	
OG1RF_10952	 2.11	 hypothetical	protein	
OG1RF_12324	 2.00	 PTT	family	thiamin	transporter	
OG1RF_11506	 2.03	 putative	lipoprotein	
OG1RF_10986	 1.98	 alpha-acetolactate	decarboxylase	
OG1RF_10271	 2.00	 hypothetical	protein	
OG1RF_12305	 2.04	 serine	protease	HtrA	
OG1RF_10338	 1.94	 organic	hydroperoxide	resistance	protein	
OG1RF_10775	 1.98	 drug:H+	antiporter-1	family	protein	
OG1RF_12070	 1.89	 hypothetical	protein	
OG1RF_11235	 1.93	 PTS	family	porter	component	IIA	
OG1RF_12494	 1.89	 ChpA/MazF	transcriptional	modulator	
OG1RF_10720	 1.85	 putative	lipoprotein	
OG1RF_11303	 1.86	 cysteine	synthase	
OG1RF_11505	 1.84	 hypothetical	protein	
OG1RF_11246	 1.83	 glyceraldehyde-3-phosphate	dehydrogenase	
OG1RF_12360	 1.82	 lactoylglutathione	lyase	
OG1RF_12488	 1.81	 DNA	starvation/stationary	phase	protection	protein	Dps	
OG1RF_10632	 1.80	 pentapeptide	repeat	family	protein	
OG1RF_10359	 1.83	 ferrous	iron	transport	protein	A	
OG1RF_11836	 1.84	 acylphosphatase	
OG1RF_10540	 1.79	
oligopeptide	ABC	superfamily	ATP	binding	cassette	transporter,	binding	
protein	
OG1RF_11745	 1.75	 protein	of	hypothetical	function	DUF1696	
OG1RF_10117	 1.72	 lipase/acylhydrolase	
OG1RF_12047	 1.78	 regulatory	protein	Spx	
OG1RF_10666	 1.71	 methylglyoxal	synthase	
OG1RF_10049	 1.70	 Veg	protein	
OG1RF_10085	 1.73	 diacylglycerol	kinase	catalytic	domain	protein	
OG1RF_10218	 1.75	 thioesterase	
OG1RF_10603	 1.71	 P-ATPase	superfamily	P-type	ATPase	copper	(Cu)	transporter	
OG1RF_10985	 1.68	 acetolactate	synthase	
OG1RF_10237	 1.65	 riboflavin	biosynthesis	protein	RibD	domain	protein	
OG1RF_11222	 1.67	 family	S9	peptidase	
OG1RF_11080	 1.68	 chaperone	DnaJ	
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OG1RF_11379	 1.63	 short	chain	dehydrogenase	
OG1RF_12337	 1.65	 hydrolase	
OG1RF_10140	 1.60	 putative	alcohol	dehydrogenase	(NADP(+))	
OG1RF_11981	 1.59	 PTS	family	glucitol/sorbitol	porter	component	IIA	
OG1RF_12046	 1.57	 adapter	protein	MecA	
OG1RF_12228	 1.58	 tetrahydrofolate	synthase	
OG1RF_11999	 1.57	 P-ATPase	superfamily	P-type	ATPase	cadmium	transporter	
OG1RF_12232	 1.52	 thiol	peroxidase	
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CHAPTER 4: DISCUSSION 
 
4.1 Colitis-associated factors influence intestinal microbial composition and transcription 
Although intestinal microbiota likely play a role in the development of human IBDs, direct 
evidence that microbes cause human IBDs is difficult to obtain using cross sectional studies of 
IBD patients. Animal models are important tools for studying how microbes influence the 
development of experimental colitis in particular and for understanding the pathogenesis of 
human IBDs in general. However, in conventionally housed animals, their intestinal microbiota 
is too complex to precisely define and manipulate component species and strains. On the other 
hand, mono- or dual- colonized animals have an overly-simplified microbiota that poorly 
represents the natural gastrointestinal microbial environment. In the current studies, we report 
using a novel simplified, defined (i.e. composed of well-characterized strain isolates with 
sequenced genomes) microbial consortium to study microbe-host and microbe-microbe 
interactions. Because we use defined microbes, we can more easily track and interpret bacterial 
transcriptome profiles.  
Others have previously shown that experimental colitis is associated with altered luminal 
bacterial transcriptomes in E. faecalis mono-colonized mice. For example, Ocvirk et al. reported 
that E. faecalis virulence genes, sprE (OG1RF_11525), gelE (OG1RF_11526), and fsr-locus 
(OG1RF_11527 ~ 11529), are upregulated in Il10-/- mice mono-colonized with E. faecalis for 16 
weeks (Ocvirk et al., 2015). However, these genes were not upregulated in E. faecalis from mice 
with colitis in our experiments. This discrepancy might be due to differences in microbial 
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complexity (mono-association vs. oct-association), observation time (16 weeks vs 10 weeks), or 
sampling location (colonic content vs. cecal content). Future studies are needed to determine 
how the presence of other bacterial species impacts the E. faecalis transcriptome during colitis. 
Another transcriptome analysis of E. faecalis, but in non-inflamed mice, was reported by 
Lindenstrauß et al. They used microbial RNA-seq to identify potential adaptive fitness genes in 
E. faecalis OG1RF during colonization of the mouse intestinal tract (Lindenstrauß et al., 2014). 
They found 124 differentially expressed genes in luminal E. faecalis from mono-colonized WT 
129 SvEv mice from Taconic compared with E. faecalis growing in exponential phase in BHI 
broth. These 124 microbial genes are involved in energy metabolism, transport and binding 
mechanisms, and fatty acid metabolism. Interestingly, they found that PTS EIIgnt and PTS 
EIIB11615 are up-regulated in E. faecalis in the mouse intestinal tract vs. BHI broth. This suggests 
that E. faecalis adapts to the environment of the non-inflamed colon by upregulating 
transcription of these PTS operons and that the presence of colitis induces additional 
upregulation. The factors responsible for upregulation of these PTS operons in normal and 
inflamed colons remain to be determined, but may include specific dietary or host-derived 
carbohydrates. Others have shown that mouse- rather than diet-derived gluconate facilitates E. 
coli colonization of the mouse intestine (Sweeney, Laux, & Cohen, 1996). We speculate that 
colitis reduces concentrations of preferred E. faecalis carbon/energy sources in the colon lumen 
thus forcing E. faecalis to use gluconate. 
 We and others have also studied the effects of colitis on gene transcription in E. coli 
mono-colonized mice. We found 64 up-regulated and 150 down-regulated genes in E. coli 
NC101 from Il10-/- compared with WT mice (Patwa et al., 2011). Many of the most highly up-
regulated genes encode stress response proteins such as acid tolerance protiens or heat shock 
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proteins that protect bacteria from reactive oxygen species. Also, genes that encode metabolism 
proteins such as glycerol-3phophate dehydrogenase are upregulated. In another study by Arthur 
et al., they found that E. coli NC101 from Il10-/- mice mono-colonized for 2, 12 and 20 weeks 
had a number of differentially expressed genes at 12 vs. 2 weeks, though the number was lower 
than what we had previously reported in WT vs. Il10-/- mice at ten weeks (Arthur et al., 2014). 
They observed no differentially expressed genes in E. coli from mice colonized for 20 vs. 2 
weeks. The discrepancy between these results and those from Patwa et al. could be due to 
differences in sample collection (cecal content vs. feces), colonization time (10 weeks vs. 2, 12, 
and 20 weeks), control group (WT vs. Il10-/-; Rag2-/-), and additional treatment (AOM). In the 
current studies, we did not detect any genes that were significantly differentially expressed in E. 
coli from ceca of WT vs. Il10-/- mice colonized for ten weeks with eight bacterial species. The 
discrepancy between the current E. coli transcriptome data and those we published previously in 
mono-colonized WT and Il10-/- mice is likely due to the presence of a more complex microbiota 
in the current studies. Taken together, these studies indicate that various factors including 
inflammation, diet, time, and presence of multiple bacterial species affect microbial 
transcriptome profiles in intestinal bacteria from mice. 
4.2 E. faecalis PTS EIIpnt and EII11616 
Although the E. faecalis gluconate PTS was already discovered in 1982 by Bernsmann et 
al. by a protein biochemical approach (Bernsmann, Alpert, Muss, Deutscher, & Hengstenberg, 
1982), the genes for the gluconate PTS in E. faecalis had not been identified until 2009 
(Brockmeier et al., 2009; Reinelt et al., 2009). Reinelt and Scheffek et al. reported the crystal 
structure of E. faecalis PTS EIIAgnt and showed a tightly interacting dimer of EIIAgnt (Reinelt et 
al., 2009). They also used homology modeling to suggest phosphoryl transfer reactions occur 
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between E. faecalis HPr, EIIAgnt and EIIBgnt components similar to E. coli mannose PTS 
components (Williams, Cai, Suh, Peterkofsky, & Clore, 2005). Lastly, they demonstrated direct 
interaction and phosphoryl group transfer between EIIAgnt and EIIBgnt components using a 
biochemical approach (Brockmeier et al., 2009). However, the current studies are the first report 
that demonstrates using genetic approaches that E. faecalis PTS EIIAgnt is essential for E. 
faecalis growth in media where gluconate is the sole carbon source.  
In addition to permitting gluconate utilization, E. faecalis PTS EIIAgnt may also affect E. 
faecalis virulence.  Recently, Peng et al. reported two E. faecalis PTS EII loci that regulate stress 
responses such as antioxidant or catabolite repression (Peng et al., 2017). They generated two 
PTS EIICD mutants in E. faecalis (∆pts1 and ∆pts2) and found that both mutant PTS strains had 
decreased intra-cellular survival in the J774 macrophage cell line. We have determined that the 
nucleotide sequence of their E. faecalis pts1 is highly similar to that of E. faecalis ∆EIIgnt.  
Therefore, it is plausible that E. faecalis PTS EIIAgnt may accentuate colitis in the presence of 
other bacterial species by increasing survival of E. faecalis in macrophages of the intestinal 
lamina propria. This concept is supported by work from Hondrop et al. indicating that a group A 
Streptococcus PTS regulates bacterial virulence in skin infections (Hondorp et al., 2013).  
Unfortunately, we have not yet identified the substrate for the PTS encoded by the PTS 
EIIA11616 operon; however, we have determined that E. faecalis PTS ∆EIIA11616 has a slight 
growth defect in minimal media supplemented with glucosamine, nucleosides, or ribose. 
Interestingly, concentrations of ribose are increased in feces from Winnie mice, which have a 
mutation in the Muc2 gene that results in spontaneous colitis, as compared to C57BL/6 mice  
(Robinson et al., 2016). These data suggest that colitis in general may be associated with 
increased luminal ribose concentrations and could explain why E. faecalis in mice with colitis 
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upregulate transcription of PTS EIIA11616. However, since E. faecalis PTS ∆EIIA11616 exhibit 
only a partial growth defect in ribose-containing minimal media, E. faecalis may have multiple 
pathways or PTS that facilitate ribose utilization. Genetically or pharmacologically inhibiting all 
of these ribose utilization pathways could potentially attenuate colitis more profoundly than what 
we observed in E. faecalis PTS ∆EIIA11616 colonized mice. Also, our E. faecalis PTS ∆EIIA11616 
lacks only one gene of the entire PTS operon, EIIA11616 (OG1RF_11616), which may not 
completely abolish the function of this PTS. In this case, EIIA subunits from other PTS operons 
may functionally compensate for the lack of PTS EIIA11616, though we think this is unlikely 
based on our current understanding of PTS biology in general. Perhaps deleting the entire 
OG1RF_11616-cointaining PTS operon in E. faecalis OG1RF would permit us to more 
definitively identify the substrate. Once we identify the substrate of PTS EIIA11616, we will be 
better equipped to explore mechanisms by which this PTS affects colitis.  
We recognize that the attenuated colitis we observed in mice colonized with E. faecalis 
PTS ∆EIIA11616 or E. faecalis ∆EIIgnt could be due to changes in other genes/gene expression. 
For instance, random mutations may have arisen in other loci during the generation of the mutant 
strains. Also, the attenuated colitis could be due to polar effects of the gene deletions on 
neighboring genes. In order to exclude these possibilities, we will need to generate genetic 
complemented strains of E. faecalis ∆EIIA11616 and E. faecalis ∆EIIgnt and show that these 
complemented strains no longer affect the colitis phenotype.  
4.3 The role of Bacteroides in the development of E. faecalis PTS-mediated colitis 
The presence of EIIA11616 or EIIgnt-expressing E. faecalis is associated with increased 
colitis and decreased relative abundance of two Bacteroides species in our oct-colonized mouse 
experiments. This suggests that Bacteroides species may attenuate colitis in this animal model 
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system. Others has previously shown that Bacteroides fragilis polysaccharide A (PSA) is 
immuno-regulatory and increases regulatory T cell function to prevent colitis development 
(Surana & Kasper, 2012). Mono-colonization of Il10-/- mice with Bacteroides vulgatus does not 
induce colitis (Sellon et al., 1998).  
Still other reports suggest a pro-inflammatory role of Bacteroides species. Mono-
colonization of HLA-B27 transgenic rats with Bacteroides vulgatus induces colitis (Rath, 
Wilson, & Sartor, 1999).  Bacteroides thetaiotaomicron (B. theta) is associated with worse 
colitis in CD4-dnTgfb2; Il10rb-/- mice (Benjdia & Berteau, 2016; Hickey et al., 2015). However, 
we do not know B. theta’s role in the Il10-/- mouse colitis model. 
To summarize, there are conflicting reports about the effects of Bacteroides species on 
experimental colitis. The type of animal model, the presence of other bacterial species, and 
length of colonization may explain some of the variability. We have found that Il10-/- mice 
mono-colonized with E. faecalis vs. tri-colonized with E. faecalis + B. vulgatus + B. theta have 
similar degrees of colitis (data not shown). Therefore, if B. vulgatus and B. theta attenuate colitis 
in Il10-/- mice, the presence of yet other bacterial species from our mixture of eight species is 
required. To determine this, we would need to perform additional experiments in which mice are 
selectively colonized with various combinations of the eight bacteria. 
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CHAPTER 5: CONCLUSIONS AND FUTURE PERSPECTIVES 
 
Cross-sectional epidemiological studies have shown that dysbiosis of the intestinal 
microbiota is associated with IBDs. Our findings demonstrate that E. faecalis PTS impact the 
ecological structure of the intestinal microbiome through interactions with other bacteria. We 
also show that adaptive responses of gut bacteria to host inflammation, including upregulation of 
transcription of certain PTS, impacts the pathogenesis of experimental colitis.  
This work lays the foundation for studies that could help to improve our understanding of 
host-microbial-environmental interactions in the intestine and that could lead to the development 
of safe and effective oral, luminally active IBD therapies that selectively target bacterial 
pathways.  
Future studies should characterize detailed mechanisms of how E. faecalis PTS participate 
in the development of colitis. For example, what is the substrate of PTS EII11616 and how do it 
and gluconate affect IBDs in animals and humans? How does intestinal inflammation affect the 
concentrations of the substrates in the intestine? What is the source of substrates in the inflamed 
intestine? Does modifying luminal concentrations of these PTS substrates impact intestinal 
inflammation? Do these PTS systems affect virulence mechanisms of E. faecalis or other 
bacteria? What is the effect of global PTS regulation in E. faecalis on colitis? Could novel 
bacteriophages be engineered to selectively deliver CRISPR-Cas9 machinery to intestinal 
bacteria and delete specific genes such as E. faecalis PTS genes as an IBD therapy? 
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